检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]河南省人民医院儿科,郑州450000 [2]武汉大学人民医院儿科,武汉430060
出 处:《中国小儿血液与肿瘤杂志》2013年第2期61-64,共4页Journal of China Pediatric Blood and Cancer
摘 要:目的观察核因子-κB(NF-κB)信号通路的阻断剂吡咯烷二硫代氨基甲酸盐(PDTC)对人白血病HL-60细胞凋亡的影响,研究其对肿瘤坏死因子α(TNF-α)、多药耐药基因1(MDR-1)表达的影响,探讨其降低HL-60细胞耐药的新机制。方法流式细胞仪检测不同浓度PDTC及PDTC(150μmol/L)联合阿糖胞苷(Ara-C)对HL-60细胞凋亡的影响;ELISA法检测不同浓度PDTC作用后HL-60细胞TNF-α水平变化;RT-PCR法分析HL-60细胞中MDR-1 mRNA的表达情况。结果不同浓度PDTC作用后HL-60细胞凋亡率均高于对照组(P<0.05),且随药物浓度的增高而增加;PDTC(150μmol/L)作用后可增强Ara-C诱导HL-60细胞凋亡;不同浓度PDTC作用后HL-60细胞TNF-α水平及MDR-1 mRNA的表达量均低于对照组(P<0.05),且随药物浓度的增高而降低。结论 PDTC可诱导HL-60细胞凋亡,增强HL-60细胞对Ara-C化疗敏感性,其机制可能与PDTC抑制NF-κB的信号转导通路,下调TNF-α、MDR-1 mRNA水平有关。Objective To discuss the effect of pyrrolidine dithiocarbama (PDTC), a selective inhibitor of NF-κB, on the apoptosis of human HL-60 cells and analyze the expression levels of TNF-α and MDR-1 in HL-60 treated by PDTC in order to explore the new mechanism of PDTC in drug resistance of tumor cells. Methods Human HL-60 ceils were treated with PDTC and Ara-C. The cell apoptosis was detected by flow cytometry (FCM) ; the expression levels of TNF-α were measured by Enzyme-linked immunosorbent assay (ELISA) ; the mRNA levels of MDR-1 were detected by RT-PCR. Results The apoptotic rates of HL-60 cells induced by different concentrations of PDTC were higher compared with the control (P 〈 0. 05 ), which could enhance the cell apoptosis induced by Ara-C in a dose-dependent manner. The levels of TNF-α and MDR-1 decreased after PDTC treatment in a non-dose-dependent manner (P 〈 0. 05). Conclusions PDTC could induce the apoptosis of HL-60 cells and enhance the chemotherapeutic sensitivity of HL-60 cells to Ara-c. PDTC may down-regulate the expression levels of TNF-α and MDR-1 by inhibiting NF-κB signal transduction.
关 键 词:NF—κB 吡咯烷二硫代氨基甲酸盐 多药耐药基因1 肿瘤坏死因子Α
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.112